New technologies and care plans aim to enhance treatment options for patients in Mitchell and the surrounding area ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous ...
Approval of Journavx for acute pain marks the first new class of acute pain medication approved by the FDA in over 20 years.